A comparative study on erlotinib & gefitinib therapy in non-small cell lung carcinoma patients

BACKGROUND & OBJECTIVES: Tyrosine kinase inhibitors (TKIs) targeting the epidermal growth factor receptor (EGFR) have been evaluated in patients with advanced non-small cell lung cancer (NSCLC). Erlotinib and gefitinib are the first-generation EGFR-TKIs for patients with NSCLC. However, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Preenumol, Vincent, Bini, George, Christeena, Joshua, Julie Mariam, Pavithran, K., Vijayan, Meenu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798608/
https://www.ncbi.nlm.nih.gov/pubmed/31571631
http://dx.doi.org/10.4103/ijmr.IJMR_1896_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798608/
https://www.ncbi.nlm.nih.gov/pubmed/31571631
http://dx.doi.org/10.4103/ijmr.IJMR_1896_17

Ejemplares similares